Dr. Paul Yamauchi
Claim this profileClinical Science Institute
Studies Plaque Psoriasis
Studies Atopic Dermatitis
13 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Paul Yamauchi is currently running
Litifilimab
for Cutaneous Lupus Erythematosus
This trial is testing BIIB059, a new medicine that targets specific immune cells, in patients with skin lupus who haven't responded to standard treatments. The goal is to see if it can reduce their skin symptoms by calming down these immune cells.
Recruiting0 awards Phase 2 & 34 criteria
TAK-279
for Psoriasis
The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet the study rules. Participants will be in the study for up to 217 weeks, including up to 35 days for the screening period, 52 weeks (Part A) up to 156 additional weeks (Part B) study treatment and 4 weeks follow up period. During the study, participants will visit their study clinic multiple times.
Recruiting2 awards Phase 31 criteria
More about Paul Yamauchi
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Paul Yamauchi has experience with
- Placebo
- Lebrikizumab
- GSK1070806
- Deucravacitinib (BMS-986165)
- LY3972406
- LY4100511
Breakdown of trials Paul Yamauchi has run
Medical Device Dermatitis
Psoriasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Yamauchi specialize in?
Paul Yamauchi focuses on Plaque Psoriasis and Atopic Dermatitis. In particular, much of their work with Plaque Psoriasis has involved treating patients, or patients who are undergoing treatment.
Is Paul Yamauchi currently recruiting for clinical trials?
Yes, Paul Yamauchi is currently recruiting for 2 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that Paul Yamauchi has studied deeply?
Yes, Paul Yamauchi has studied treatments such as Placebo, Lebrikizumab, GSK1070806.
What is the best way to schedule an appointment with Paul Yamauchi?
Apply for one of the trials that Paul Yamauchi is conducting.
What is the office address of Paul Yamauchi?
The office of Paul Yamauchi is located at: Clinical Science Institute, Santa Monica, California 90404 United States. This is the address for their practice at the Clinical Science Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.